Provided by Tiger Trade Technology Pte. Ltd.

GlaxoSmithKline PLC

48.12
-0.5100-1.05%
Post-market: 48.130.0100+0.02%19:30 EDT
Volume:2.15M
Turnover:103.57M
Market Cap:97.33B
PE:15.39
High:48.59
Open:48.47
Low:47.98
Close:48.63
52wk High:61.70
52wk Low:39.29
Shares:2.02B
Float Shares:1.94B
Volume Ratio:0.82
T/O Rate:0.11%
Dividend:1.84
Dividend Rate:3.82%
EPS(TTM):3.13
EPS(LYR):3.74
ROE:33.38%
ROA:10.01%
PB:4.08
PE(LYR):12.88

Loading ...

GSK Advances New Malaria Drug With Completed First-in-Human Study

TIPRANKS
·
Jul 09

Dow Jones Top Company Headlines at 7 am ET: Apple to Spend $30 Billion on U.s.-made Chips from Broadcom | Trump-backed ...

Dow Jones
·
Jul 08

GSK, Sino Biopharmaceutical Unit Expand Collaboration to Cover Two GSK Respiratory Therapies

MT Newswires Live
·
Jul 08

Barclays Remains a Sell on GlaxoSmithKline (GSK)

TIPRANKS
·
Jul 08

Dow Jones Top Company Headlines at 3 am ET: Sino Biopharm Strikes Drug Licensing Deal with Astrazeneca, Deepens GSK Partnership | White ...

Dow Jones
·
Jul 08

Sino Biopharm Deepens GSK Respiratory Deal to Cement China Lead

TIPRANKS
·
Jul 08

GSK’s StrateGIST Frontline Trial Puts New Cancer Drug Velzatinib in the Spotlight

TIPRANKS
·
Jul 08

Drug Pricing Pressure Puts GSK And Global Pharma Stocks In Focus

Simply Wall St.
·
Jul 07

GSK Falls Monday, Underperforms Market

Dow Jones
·
Jul 07

Pharmaceutical Sector Attracts Capital Rotation, GlaxoSmithKline Surges Nearly 5%

Stock News
·
Jul 02

Movement Alert|GSK Rises 3.02% in Regular Trading, Pharma Sector Rallies as Nuvalent Tender Offer Advances

Market Focus
·
Jul 02

GSK Slides Wednesday, Underperforms Market

Dow Jones
·
Jul 02

GSK’s New mRNA Combo Shot Targets Flu and COVID-19 in One Vaccine

TIPRANKS
·
Jul 01

GSK: Neutral Stance Maintained as Near-Term Strength Offsets Pipeline and Litigation Risks; Price Target Held at £2,350

TIPRANKS
·
Jun 30

Goldman Sachs Sticks to Their Hold Rating for GlaxoSmithKline (GSK)

TIPRANKS
·
Jun 30

GSK Completes £2 Billion Share Buyback, Lifts Treasury Holdings to 6.7% of Voting Rights

TIPRANKS
·
Jun 29

J.P. Morgan Reaffirms Their Sell Rating on GlaxoSmithKline (GSK)

TIPRANKS
·
Jun 29

GlaxoSmithKline (GSK) Gets a Sell from Barclays

TIPRANKS
·
Jun 29

GSK’s Extended Salford Lung Study: What a Terminated Data Project Still Means for Investors

TIPRANKS
·
Jun 27

Dodge & Cox lifts GSK stake above 5% as institutional backing grows

TIPRANKS
·
Jun 26